Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Insurance Settlements Receivable

2.8 / 5 stars · 68/120 Roast Me

Tempest Therapeutics, Inc. Insurance Settlements Receivable

Tempest Therapeutics, Inc. (TPST) had Insurance Settlements Receivable of $450.00 thousand as of 2022-12-31, per its 10-K filed 2024-03-19.

Discontinued › Notes › Receivables › Nontrade Receivables

us-gaap:InsuranceSettlementsReceivable · last filed 2024-03-19

  • 2022-12-31: Insurance Settlements Receivable $450.00K.
  • 2021-12-31: Insurance Settlements Receivable $15.00M.
  • 2020-12-31: Insurance Settlements Receivable $0.00.
Period endInsurance Settlements Receivable
2022-12-31$450.00K
10-K · filed 2024-03-19
2021-12-31$15.00M
10-K · filed 2023-03-22
2020-12-31$0.00
10-K · filed 2022-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B